Caisheng Wu

1.4k total citations
54 papers, 987 citations indexed

About

Caisheng Wu is a scholar working on Molecular Biology, Complementary and alternative medicine and Biomedical Engineering. According to data from OpenAlex, Caisheng Wu has authored 54 papers receiving a total of 987 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 14 papers in Complementary and alternative medicine and 8 papers in Biomedical Engineering. Recurrent topics in Caisheng Wu's work include Metabolomics and Mass Spectrometry Studies (11 papers), Traditional Chinese Medicine Analysis (8 papers) and Natural product bioactivities and synthesis (6 papers). Caisheng Wu is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (11 papers), Traditional Chinese Medicine Analysis (8 papers) and Natural product bioactivities and synthesis (6 papers). Caisheng Wu collaborates with scholars based in China, Singapore and France. Caisheng Wu's co-authors include Jinlan Zhang, Yun‐Long Wu, Zibiao Li, Qiang Ren, Feng Qu, Hongwei Cheng, Yan Ren, Zhixin Jia, Zheng Luo and Xian Jun Loh and has published in prestigious journals such as Advanced Materials, Nature Communications and PLoS ONE.

In The Last Decade

Caisheng Wu

52 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caisheng Wu China 20 388 182 169 121 110 54 987
Ran Lu China 19 526 1.4× 134 0.7× 143 0.8× 93 0.8× 54 0.5× 61 1.4k
Cuiping Jiang China 21 336 0.9× 143 0.8× 130 0.8× 80 0.7× 104 0.9× 89 1.3k
Ziming Zhao China 21 374 1.0× 333 1.8× 218 1.3× 51 0.4× 95 0.9× 56 1.1k
Chenrui Li China 20 511 1.3× 163 0.9× 140 0.8× 160 1.3× 74 0.7× 52 1.2k
Yong Seok Choi South Korea 22 424 1.1× 124 0.7× 119 0.7× 31 0.3× 52 0.5× 66 1.2k
Zhixi Chen China 18 538 1.4× 79 0.4× 79 0.5× 113 0.9× 62 0.6× 50 1.1k
Pingping Gan China 13 288 0.7× 131 0.7× 66 0.4× 88 0.7× 37 0.3× 27 787
Xiaojun Tao China 23 588 1.5× 315 1.7× 214 1.3× 66 0.5× 126 1.1× 58 1.3k

Countries citing papers authored by Caisheng Wu

Since Specialization
Citations

This map shows the geographic impact of Caisheng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caisheng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caisheng Wu more than expected).

Fields of papers citing papers by Caisheng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caisheng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caisheng Wu. The network helps show where Caisheng Wu may publish in the future.

Co-authorship network of co-authors of Caisheng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Caisheng Wu. A scholar is included among the top collaborators of Caisheng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caisheng Wu. Caisheng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Zheng, Qi Wang, Xiaotong Fan, et al.. (2025). ROS‐Driven Nanoventilator for MRSA‐Induced Acute Lung Injury Treatment via In Situ Oxygen Supply, Anti‐Inflammation and Immunomodulation. Advanced Science. 12(18). e2406060–e2406060. 5 indexed citations
2.
Du, Jun-Xian, Haiyu Wang, Lei Shen, et al.. (2025). KPNA2 silencing sensitizes triple-negative breast cancer to chemotherapy by promoting multipolar division and suppressing DNA damage repair. Oncogene. 44(44). 4254–4270. 1 indexed citations
4.
Zhang, Dandan, et al.. (2024). Advances in intelligent mass spectrometry data processing technology for in vivo analysis of natural medicines. Chinese Journal of Natural Medicines. 22(10). 900–913. 3 indexed citations
6.
Bai, Xue, Caixia Yuan, Jiyang Dong, et al.. (2023). Rapid and accurate identification of adulterated ingredients in lotus root powder based on liquid chromatography-high resolution mass spectrometry and MS-IDF. Journal of Food Composition and Analysis. 123. 105576–105576. 2 indexed citations
7.
Zhu, Chunyan, Lingjie Ke, Xiang Ao, et al.. (2023). Injectable Supramolecular Hydrogels for In Situ Programming of Car‐T Cells toward Solid Tumor Immunotherapy. Advanced Materials. 36(5). e2310078–e2310078. 40 indexed citations
8.
Shen, Jie, Lingjie Ke, Qiuping Zhang, et al.. (2022). Cholesterol-stabilized membrane-active nanopores with anticancer activities. Nature Communications. 13(1). 5985–5985. 18 indexed citations
9.
Jiang, Xiaojuan, Lin Yi-Hua, Yun‐Long Wu, et al.. (2022). Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan An He Ji oral liquid. Journal of Pharmaceutical Analysis. 12(6). 839–851. 27 indexed citations
10.
Chen, Jiayun, Rong Ding, Chunyan Zhu, et al.. (2022). HRPIF data mining based on data-dependent/independent acquisition for Rhei Radix et Rhizoma metabolite screening in rats. Journal of Chromatography B. 1190. 123095–123095. 4 indexed citations
11.
Li, Zhiguo, Lingjie Ke, Lijuan Wang, et al.. (2021). Flexible polymeric nanosized micelles for ophthalmic drug delivery: research progress in the last three years. Nanoscale Advances. 3(18). 5240–5254. 43 indexed citations
12.
Huang, Fengyu, Zhiping Zeng, Weidong Zhang, et al.. (2021). Design, synthesis, and biological evaluation of novel sulindac derivatives as partial agonists of PPARγ with potential anti-diabetic efficacy. European Journal of Medicinal Chemistry. 222. 113542–113542. 9 indexed citations
13.
Cheng, Hongwei, Zhixian Wu, Caisheng Wu, et al.. (2017). Overcoming STC2 mediated drug resistance through drug and gene co -delivery by PHB-PDMAEMA cationic polyester in liver cancer cells. Materials Science and Engineering C. 83. 210–217. 85 indexed citations
14.
Zhao, Haishan, et al.. (2016). Effects of ovarian ablation or suppression in premenopausal breast cancer: A meta-analysis of randomized controlled trials. European Journal of Surgical Oncology. 43(7). 1161–1172. 11 indexed citations
15.
16.
Qu, Feng, Sujun Zheng, Shuang Liu, et al.. (2014). Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure. PLoS ONE. 9(8). e104988–e104988. 20 indexed citations
18.
Qu, Feng, Sujun Zheng, Caisheng Wu, et al.. (2013). Lipidomic profiling of plasma in patients with chronic hepatitis C infection. Analytical and Bioanalytical Chemistry. 406(2). 555–564. 25 indexed citations
19.
Hou, Jinfeng, Feng Qu, Caisheng Wu, Qiang Ren, & Jinlan Zhang. (2012). Quantitative determination and pharmacokinetic study of the novel anti-Parkinson's disease candidate drug FLZ in rat brain by high performance liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 66. 232–239. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026